Combined neurolytic block of celiac, inferior mesenteric, and superior hypogastric plexuses for incapacitating abdominal and/or pelvic cancer pain.
Thirty-five patients with extensive abdominal or pelvic cancer who suffered uncontrolled, diffuse, extensive, and incapacitating pain were treated with a combination of neurolytic celiac plexus block (CPB), inferior mesenteric plexus block (IMPB), and superior hypogastric plexus block (SHGPB). The combination of neurolytic CPB, IMPB, and SHGPB was performed with alcohol, mainly using a transintervetebral disc approach. The combination neurolysis produced effective immediate pain relief in all the patients (visual analog scale (VAS), reduced from 8.8 +/- 0.2 to 0). This pain relief persisted during the first 3 months (VAS, 2.3 +/- 0.5) or until death. Morphine consumption was significantly decreased for the first 1 month (from 96 +/- 29 mg to 31 +/- 10 mg per day) after the neurolysis and thereafter continued to be lower than before the surgery, though not significantly so. No serious complications were observed to have been caused by the neurolytic procedure on the three sympathetic plexuses. Our preliminary clinical results suggest that the combination of neurolytic CPB, IMPB, and SHGPB improves the quality of life of patients who have incapacitating cancer pain, by reducing both the intensity of the pain and their opioid consumption, without serious complications. This combination procedure may provide a new therapeutic option for pain relief in patients with advanced cancer.
Kitoh
Takeshi
T
Department of Anesthesia, Nagano Municipal Hospital, 1331-1 Tomitake, Nagano 381-8551, Japan.
Tanaka
Satoshi
S
Ono
Koichi
K
Ohfusa
Yukihiro
Y
Ina
Hiroaki
H
Otagiri
Tetsutaro
T
D000008:Abdominal Neoplasms / Q000188:drug therapy*; D015746:Abdominal Pain / Q000188:drug therapy / Q000209:etiology; D000701:Analgesics, Opioid; D002447:Celiac Plexus; D002492:Central Nervous System Depressants / Q000627:therapeutic use*; D000431:Ethanol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007001:Hypogastric Plexus; D008297:Male; D008643:Mesentery / Q000294:innervation; D009020:Morphine; D009407:Nerve Block; D010148:Intractable Pain / Q000188:drug therapy* / Q000209:etiology; D010386:Pelvic Neoplasms / Q000188:drug therapy*; D017699:Pelvic Pain / Q000188:drug therapy / Q000209:etiology; D011788:Quality of Life
D000701:Analgesics, Opioid; D002492:Central Nervous System Depressants; D000431:Ethanol; D009020:Morphine